KKD Healthcare Analytics | TalkMarkets | Page 2

KKD Healthcare Analytics

Healthcare Expert With 30 Years Experience
Contributor's Links: Dr KKD Healthcare Stock Tips

KKD Healthcare Analytics is a niche healthcare investment advisory service. Our goal is to channel our medical knowledge and long track record as a private investor into a website that will be the ultimate go-to place for knowledge and information about biotech ...more

Following: 17 Followers: 2328

Articles

Latest Posts
17 to 32 of 67 Posts
<<< 1 2 3 4 5 >>>
Alnylam (ALNY) Stock To Maintain Momentum With New Patent Win
Thursday, June 15, 2017 9:18 AM EDT
Alnylam Pharmaceuticals Inc. boosted its patent portfolio with new allowances from USPTO as the regulatory authority issued the notices with regard to the patent application.
In this article: ALNY
Read
Premarket Biotech Digest – RDHL Initiates Two Products. BMY Starts Recall, PULM Inks New Deal
Wednesday, June 14, 2017 9:07 AM EDT
RedHill Biopharma stock perked up as the company announced starting two GI-focused products in the U.S. Aptose Biosciences stock is on rally as the company announced updates for its pipeline candidates CG'806 and APTO-253.
In this article: RDHL, APTO, BMY, ENDP, PFE, NURO, PULM, ABBV
Read
Upcoming Monitoring System Makes Iradimed A Good Mid-Term Investment
Tuesday, June 13, 2017 10:07 AM EDT
For the second quarter of the year, iRadimed Corp. expects its revenue to be in the range of $5.4 million to $5.5 million while its first quarter revenue stood at $5.2 million.
In this article: IRMD
Read
Premarket Biotech Digest – JNJ Receives EU Nod, XBIT Terminates Trial, PFE Amends Protocol
Monday, June 12, 2017 9:17 AM EDT
Johnson & Johnson announced receiving the approval from the regulatory authorities in the EU for its planned $30 billion takeover of Actelion. Teva announced the commercial launch of the generic version of Novartis’ Pataday.
In this article: JNJ, LXRX, PFE, TEVA, XBIT, TSRO, EYEG
Read
Sonoma Pharmaceuticals: Upcoming Catalyst Presents Second Opportunity For Those Who Missed The Boat Earlier
Tuesday, June 6, 2017 3:37 PM EDT
Sonoma Pharmaceuticals operates in dermatological care segment, which is considered rather low-risk area of pharmacology. The valuations of the company are also on the cheaper side, which is expected to reward the early spotters at the later stage.
In this article: SNOA
Read
Premarket Biotech Digest – AVGR Announces Positive Data, CXRX To Be Investigated
Thursday, June 1, 2017 8:26 AM EDT
Microbot Medical Inc. (MBOT) announced receiving a new patent from the Canadian Intellectual Property Office. Avinger (AVGR) stock soared as the company announced the positive 24 month data from the VISION study.
In this article: PSTV Also: APHB, JAZZ, NSTG, AVGR, CXRX, MBOT
Read
Premarket Biotech Digest – RDUS Reports Positive Results, RHHBY Investigates Case, QDEL Receives Japanese Approval
Thursday, May 25, 2017 9:50 AM EDT
Aerie Pharmaceuticals announced positive results from its Phase 3 clinical trial, Mercury 2. Puma Biotechnology is reprorted to have received 12-4 approval from an FDA advisory committee for its experimental breast cancer drug.
In this article: JNJ, MDT, RHHBY, QDEL, PBYI, RDUS, AERI, RVVTF, RNVA
Read
Premarket Biotech Digest – OCX Reports Positive Results, ELTP Acquires ANDA
Tuesday, May 23, 2017 7:22 AM EDT
OncoCyte Corp stock surged as the company announced positive results in the development of a blood-based diagnostic test for lung cancer.
In this article: AZN, CYH, MRK, SNY, NURO, REGN, PRGO, ELTP, TARO, FLXN, OCX
Read
Premarket Biotech Digest – AMGN Announces Positive Results, FOLD Completes Analysis Plan, JNJ Files Lawsuit
Monday, May 22, 2017 9:41 AM EDT
Amgen Inc. announced that it has received positive results from a Phase 3 clinical trial. AstraZeneca announced selling the European rights to its aging beta-blocker heart drug Seloken to Italian company Recordati.
In this article: AZN, BMY, JNJ, FOLD, AMGN, MYL, INSM, GBSN
Read
Premarket Biotech Digest – Teva, MannKind, Quidel, Applied DNA Sciences Reported Earnings
Friday, May 12, 2017 5:40 AM EDT
Teva Pharmaceutical Industries announced its first quarter results. Applied DNA Sciences reported its second quarter loss at $3.4 million.
In this article: BSX, MNKD, QDEL, STAA, TEVA, XNCR, CRBP, AIMT, APDN, NSPR
Read
Biotech Digest – BSX Gets FDA Nod, AMRS Inks Equity Deal, XRAY Reports Q1 Results
Tuesday, May 9, 2017 7:50 AM EDT
Array Biopharma Inc. announced its new collaboration with Merck for a clinical trial. Boston Scientific Corporation announced that the FDA has approved its Resonate family of implantable cardioverter defibrillator.
In this article: BSX, JNJ, ALXN, ARRY, AMRS, ENDP, XRAY, PTCT, KITE
Read
Premarket Biotech Digest – ANTM May Increase Premium, IPXL Receives FDA Approval, ZTS Receives EC Nod
Thursday, April 27, 2017 7:20 AM EDT
Impax Laboratories announced receiving the FDA approval for its its generic version of cholesterol drug Vytorin. Anthem said that its premium may increase by 20 percent or more pursuant to the loss of federal subsidies supporting Obamacare plans.
In this article: AZN, DDD, ALNY, IPXL, MNOV, UTHR, ZTS, ANTM, FLKS
Read
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Tuesday, April 25, 2017 10:15 AM EDT
Capricor Therapeutics announced encouraging six-month results in a Phase 1/2 clinical trial. Jazz Pharmaceuticals reported results from its Phase 2/3 clinical trial. Amgen announced its new collaboration with Novartis.
In this article: NVS, EAPH, ACHN, JAZZ, AMGN, CANF, CAPR, CTSO
Read
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Monday, April 24, 2017 10:03 AM EDT
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read
Premarket Biotech Digest – NOVN Reports Topline Results, INNV Receives New Patent, AIQ Signs Merger Agreement
Wednesday, April 12, 2017 9:50 AM EDT
Novan stock skyrocketed as the company reported positive topline results from the Company’s Phase 2 clinical trial with SB208. Alliance HealthCare Services announced signing a definitive merger agreement with Tahoe Investment Group.
In this article: AIQ, PLX, AVEO, BCRX, NBIX, MZOR, NOVN
Read
Premarket Biotech Digest – CBMG Inks New Deal, IPCI Sued, SYRS Gets FDA Nod
Tuesday, April 11, 2017 9:34 AM EDT
Geron Corporation stock picked up on the news that the company has agreed to a settlement related to a consolidated class-action securities lawsuit. The company stock jumped over 19 percent in its previous trading session.
In this article: TXMD, GERN, IPCI, RPRX, GBLX, OMED, CBMG, SYRS
Read
17 to 32 of 67 Posts
<<< 1 2 3 4 5 >>>